Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry.
Saved in:
| Title: | Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry. |
|---|---|
| Authors: | Correll, Colleen1 (AUTHOR), Burciu, Alis2 (AUTHOR), Bansal, Amita2 (AUTHOR), Dennos, Anne3 (AUTHOR), Narayanswamy, Deepak4 (AUTHOR), Aubrun, Elodie2 (AUTHOR), Schanberg, Laura E.5 (AUTHOR), Yuhan, Li6 (AUTHOR), Schneider, Rahel2 (AUTHOR), Balevic, Stephen5 (AUTHOR), Kimura, Yukiko7 (AUTHOR), Beukelman, Timothy8 (AUTHOR) tbeukelman@carragroup.org, Aamir, R. (AUTHOR), Adams, A. (AUTHOR), Aguiar Lapsia, C. (AUTHOR), Ahmed, H. (AUTHOR), Akoghlanian, S. (AUTHOR), AlBijadi, A. (AUTHOR), Allenspach, E. (AUTHOR), Amarilyo, G. (AUTHOR) |
| Source: | Pediatric Rheumatology. 10/21/2025, Vol. 23 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
